WCBA
Weaver C. Barksdale & Associates’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $11K | Buy |
97
+5
| +5% | +$567 | 0.01% | 261 |
|
|
2017
Q3 | $10K | Sell |
92
-6
| -6% | -$652 | 0.01% | 270 |
|
|
2017
Q2 | $10K | Sell |
98
-19
| -16% | -$1.94K | 0.01% | 266 |
|
|
2017
Q1 | $11K | Hold |
117
| – | – | 0.01% | 257 |
|
|
2016
Q4 | $9K | Buy |
117
+28
| +31% | +$2.15K | 0.01% | 287 |
|
|
2016
Q3 | $7K | Buy |
89
+17
| +24% | +$1.34K | 0.01% | 319 |
|
|
2016
Q2 | $6K | Hold |
72
| – | – | 0.01% | 329 |
|
|
2016
Q1 | $5K | Hold |
72
| – | – | ﹤0.01% | 379 |
|
|
2015
Q4 | $6K | Sell |
72
-11
| -13% | -$917 | ﹤0.01% | 344 |
|
|
2015
Q3 | $5K | Hold |
83
| – | – | ﹤0.01% | 373 |
|
|
2015
Q2 | $6K | Hold |
83
| – | – | ﹤0.01% | 353 |
|
|
2015
Q1 | $7K | Hold |
83
| – | – | 0.01% | 332 |
|
|
2014
Q4 | $5K | Sell |
83
-7
| -8% | -$422 | ﹤0.01% | 372 |
|
|
2014
Q3 | $5K | Sell |
90
-5
| -5% | -$278 | ﹤0.01% | 361 |
|
|
2014
Q2 | $5K | Buy |
95
+13
| +16% | +$684 | ﹤0.01% | 378 |
|
|
2014
Q1 | $5K | Sell |
82
-18
| -18% | -$1.1K | ﹤0.01% | 373 |
|
|
2013
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 376 |
|
|
2013
Q3 | $5K | Sell |
100
-9
| -8% | -$450 | ﹤0.01% | 371 |
|
|
2013
Q2 | $4K | Buy |
+109
| New | +$4K | ﹤0.01% | 400 |
|